Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antiviral Drugs Market

Antiviral Drugs Market Share

Report ID: GMI4968
Published Date: Mar 2022
Report Format: PDF

Download Free Sample

Antiviral Drugs Market Share

Some of the notable key market players operating in the antiviral drug industry include :

Gilead Sciences
AbbVie, Inc.
Merck & Co.
GlaxoSmithKline plc
Aurobindo Pharma Limited.
ohnson & Johnson
Sun Pharmaceutical Industries Ltd.
Cipla, Inc.
Mylan N V
Bristol-Myers Squibb

These industry players are adopting several growth strategies to strengthen product offerings and attain sustainable competitive advantage.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for antiviral drugs exceeded USD 48 billion in 2021 and is anticipated to grow at a CAGR of 3.4% between 2022 and 2028 considering the higher incidence rate of infectious diseases.

Branded antiviral drugs industry value is expected to grow at a CAGR of 2.9% through 2028 driven by the rising product adoption and availability in developed markets.

North American market for antiviral drugs accounted for more than 56% of the total industry value in 2021 and will record substantial growth over 2022-2028 owing to the escalating number of product approvals.

Key participants in the antiviral drugs industry comprise Aurobindo Pharma Limited, Gilead Sciences, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Cipla, Inc., Johnson & Johnson, and others.